# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-25-247658
Filing Date
2025-10-23
Accepted
2025-10-23 07:04:40
Documents
33
Period of Report
2025-10-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d88744d8k.htm iXBRL | 8-K | 27808
2 | EX-99.1 | d88744dex991.htm | EX-99.1 | 27959
6 | GRAPHIC | g88744ex99_1s10g1.jpg | GRAPHIC | 73678
7 | GRAPHIC | g88744ex99_1s11g1.jpg | GRAPHIC | 59023
8 | GRAPHIC | g88744ex99_1s12g1.jpg | GRAPHIC | 70050
9 | GRAPHIC | g88744ex99_1s13g1.jpg | GRAPHIC | 90333
10 | GRAPHIC | g88744ex99_1s14g1.jpg | GRAPHIC | 60102
11 | GRAPHIC | g88744ex99_1s15g1.jpg | GRAPHIC | 88511
12 | GRAPHIC | g88744ex99_1s16g1.jpg | GRAPHIC | 55943
13 | GRAPHIC | g88744ex99_1s17g1.jpg | GRAPHIC | 60551
14 | GRAPHIC | g88744ex99_1s18g1.jpg | GRAPHIC | 67960
15 | GRAPHIC | g88744ex99_1s19g1.jpg | GRAPHIC | 88448
16 | GRAPHIC | g88744ex99_1s1g1.jpg | GRAPHIC | 47486
17 | GRAPHIC | g88744ex99_1s20g1.jpg | GRAPHIC | 87577
18 | GRAPHIC | g88744ex99_1s2g1.jpg | GRAPHIC | 246165
19 | GRAPHIC | g88744ex99_1s3g1.jpg | GRAPHIC | 78731
20 | GRAPHIC | g88744ex99_1s4g1.jpg | GRAPHIC | 37971
21 | GRAPHIC | g88744ex99_1s5g1.jpg | GRAPHIC | 77625
22 | GRAPHIC | g88744ex99_1s6g1.jpg | GRAPHIC | 109562
23 | GRAPHIC | g88744ex99_1s7g1.jpg | GRAPHIC | 51144
24 | GRAPHIC | g88744ex99_1s8g1.jpg | GRAPHIC | 67516
25 | GRAPHIC | g88744ex99_1s9g1.jpg | GRAPHIC | 75664
| Complete submission text file | 0001193125-25-247658.txt |  | 2377772

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | tngx-20251023.xsd | EX-101.SCH | 2850
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | tngx-20251023_lab.xml | EX-101.LAB | 17994
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | tngx-20251023_pre.xml | EX-101.PRE | 11261
35 | EXTRACTED XBRL INSTANCE DOCUMENT | d88744d8k_htm.xml | XML | 3634

Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39485 | Film No.: 251411375
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)